Semaglutide improves walking ability in patients with peripheral artery disease and type 2 diabetes
1. Maximum walking distance at 52 weeks was significantly improved with semaglutide. 2. There were fewer treatment-related serious adverse events ...
Tag: peripheral vascular disease
![Novel biodegradable sirolimus-eluting stents non-inferior to durable everolimus-eluting stents [BIOSCIENCE trial]](https://www.2minutemedicine.com/wp-content/uploads/2014/09/Taxus_stent_FDA-e1607803635904-350x250.jpg)
No increase in mortality with paclitaxel-coated devices among patients with femoropopliteal disease
1. There was no significant increase in mortality between the paclitaxel-coated and control devices in both the intention-to-treat and as-treated ...
Best endovascular treatment superior to vein bypass for patients with chronic limb ischemia requiring infrapopliteal revascularization
1. Major amputation and all-cause mortality were higher in the vein bypass group compared to the best endovascular treatment group. ...
Prolonged DAPT following PCI linked to fewer ischemic events in patients with PAD
1. Subgroup analysis of the PRODIGY trial demonstrated that there were lower rates of ischemic events in patients with baseline ...
Mild hyperglycemia associated with low prevalence of vascular complications
Image: PD 1. Glucokinase (GCK) mutation carriers, who are in a state of mild hyperglycemia since birth, demonstrated a low ...
Home-based walking program an effective treatment for peripheral artery disease
Image: PD 1. Home-based therapy intervention that provides a support structure via a group program increases the distance and speed ...
